Toulouse, France

Christophe Boldron

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Christophe Boldron

Introduction

Christophe Boldron is a notable inventor based in Toulouse, France. He has made significant contributions to the field of chemistry, particularly in the development of polyquinoline derivatives. His work focuses on therapeutic applications that address critical health issues.

Latest Patents

Christophe Boldron holds 2 patents. His latest patents include "Polyquinoline derivatives and the therapeutic use thereof." This invention relates to a method for chelating metal ions and dissolving amyloid aggregates. It involves using a compound of formula (I) to achieve these therapeutic effects. Another patent under his name is also titled "Polyquinoline derivatives and therapeutic use thereof," which details the compounds of general formula (I), the process for their preparation, and their use as therapeutic agents.

Career Highlights

Throughout his career, Christophe has worked with prominent organizations such as Palumed S.A. and the Centre National de la Recherche Scientifique. His experience in these institutions has allowed him to advance his research and contribute to significant scientific advancements.

Collaborations

Christophe has collaborated with esteemed colleagues, including Marguerite Pitie and Bernard Meunier. These partnerships have enriched his research and expanded the impact of his inventions.

Conclusion

Christophe Boldron's innovative work in the field of polyquinoline derivatives showcases his dedication to advancing therapeutic methods. His contributions are vital in addressing complex health challenges, and his patents reflect his commitment to scientific progress.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…